TIRUMALCHM2024-10-012024-12-31 TIRUMALCHM2024-10-012024-12-31 TIRUMALCHM2024-10-012024-12-31in-bse-fin:OneOperatingExpenses01Member TIRUMALCHM2024-10-012024-12-31in-bse-fin:FourOperatingExpenses01Member TIRUMALCHM2024-12-31 TIRUMALCHM2024-10-012024-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member TIRUMALCHM2024-10-012024-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member TIRUMALCHM2024-10-012024-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss03Member TIRUMALCHM2024-10-012024-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member TIRUMALCHM2024-10-012024-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss02Member TIRUMALCHM2024-10-012024-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss03Member TIRUMALCHM2024-10-012024-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member TIRUMALCHM2024-10-012024-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss02Member TIRUMALCHM2024-10-012024-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member TIRUMALCHM2024-10-012024-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 500412 TIRUMALCHM NA Thirumalai Chemicals Limited Equity 2024-04-01 2025-03-31 2025-01-28 2025-01-17 INR Lakhs Third quarter 10:30:00 14:15:00 2025-01-28 2025-01-28 Not applicable Single segment Chemical products and its intermediaries 2024-10-01 2024-12-31 Unaudited Consolidated 4466500000.00 2000000.00 4468500000.00 3227100000.00 9900000.00 381600000.00 253500000.00 143500000.00 155400000.00 796600000.00 4967600000.00 -499100000.00 0.00 -499100000.00 -26100000.00 -52800000.00 -78900000.00 0.00 -420200000.00 0.00 0.00 0.00 0.00 -420200000.00 281600000.00 -138600000.00 0.00 0.00 102400000.00 1 -4.10 -4.10 0.00 0.00 -4.10 -4.10 1. The Audit Committee has reviewed and the Board of Directors have approved the above results at their respective meetings held on 27 January 2025 and 28 January 2025 respectively. The Statutory Auditors of the Company have carried out Limited Review of the aforesaid results. 2. In accordance with Ind AS 108, Operating Segments, the Group has identified manufacture and sale of organic chemicals as the only reportable segment. 3. The standalone and consolidated financial results have been prepared in accordance with recognition and measurement principles laid down in the Indian Accounting Standard 34, Interim financial reporting (Ind AS 34), prescribed under Section 133 of the Companies Act 2013, and other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of the regulation 33 of the SEBI (Listing obligation and disclosure requirements) Regulations, 2015 as amended. 4. The consolidated financial results of the Company includes results of its subsidiaries as on 31 December 2024 as per the applicable Indian Accounting Standards. List of subsidiaries as on 31 December 2024 are provided in table below. Name of the subsidiary Country of incorporation Optimistic Organic Sdn. Bhd Malaysia Cheminvest Pte Ltd. Singapore Lapiz Europe Limited Europe TCL Global B.V The Netherlands TCL Inc. United States of America TCL Specialties LLC United States of America TCL Intermediates Pvt Ltd India Single segment 2024-04-01 2024-12-31 Unaudited Consolidated 15264500000.00 128200000.00 15392700000.00 11819400000.00 36300000.00 74300000.00 673400000.00 338800000.00 427500000.00 2321400000.00 15691100000.00 -298400000.00 0.00 -298400000.00 152500000.00 -130500000.00 22000000.00 0.00 -320400000.00 0.00 0.00 0.00 0.00 -320400000.00 918400000.00 598000000.00 0.00 0.00 102400000.00 1 -3.13 -3.13 0.00 0.00 -3.13 -3.13 Other Expenses 796600000.00 Other Expenses 2321400000.00 Re-measurements of defined benefit plans -400000.00 Equity instruments through other comprehensive income, net 94300000.00 Income tax relating to items that will not be reclassified to profit and loss -13500000.00 Re-measurements of defined benefit plans -3500000.00 Equity instruments through other comprehensive income, net 858500000.00 Income tax relating to items that will not be reclassified to profit and loss -132100000.00 80400000.00 722900000.00 0.00 0.00 Exchange differences on translation of foreign operations 124500000.00 Cash flow hedge reserve 76700000.00 Exchange differences on translation of foreign operations 122700000.00 Cash flow hedge reserve 72800000.00 201200000.00 195500000.00 0.00 0.00